Head, Division for Coordination of Common Market for Drugs and Medical Devices Formation
Eurasian Economic Commission
Chief Expert, Methodology and Internal Administration Division, Department of Technical Regulation and Accreditation
Eurasian Economic Commission
Clinical Research Director, Non-Foot Print Countries
GSK
Director of Clinical Site Management, Russia and Belarus
Pfizer
Country Head of Site Management
Bayer
Chief Medical Officer
R-Pharm
Clinical Research Director
AstraZeneca Russia
Head of Clinical Operations
Novartis Pharma
Head of Clinical Trials Management, Russian Innovation Centre
Takeda Pharmaceuticals
Clinical Trials Director, Russia & EAEU countries
Servier
Director, Clinical Development
GEROPHARM
Head of Biostatistics
Synergy Research Group
Chief Operating Officer
IPHARMA
Compliance Process, Training & Systems Manager, PDG Country Clinical Operations, CEETRISMEA
F.Hoffmann-La Roche Ltd.
Co-Chairman
Russian Patients Association
Director of High School of Molecular and Experimental Medicine
Dmitry Rogachev National Research Center
Head of the Department for Optimization of Treatment for Adolescents and Young Adults with Oncological Diseases
Rogachev Federal Scientific and Clinical Centre of Pediatric Hematology Oncology and Immunology
Head of Translational and Cell Research Department
Rogachev Federal Scientific and Clinical Centre of Pediatric Hematology Oncology and Immunology
Endocrinologist
Russian Railways Clinical Hospital, Chelyabinsk
Head, Scientific Research Laboratory of Clinical Trials and Evidence-Based Medicines of Preclinical and Clinical Research Centre
Almazov National Medical Research Centre
Director of Data Management
IPHARMA
Insights from 40+ experts: regulators, representatives of international and Russian pharmaceutical producers, CROs and investigators
2-day information-rich programme that includes insightful presentations from leading sector players, interactive debates and round tables
Unrivalled networking opportunities with 150+ attendees from such companies as AstraZeneca, Pfizer, Novartis, Bayer, Biocad, R-Pharm and many more
Unique opportunity for all the clinical trials sector players to meet and discuss the most burning issues.
The forum brings together representatives of all stakeholder groups involved in clinical trials – sponsors, CROs, regulators and investigators for a constructive dialogue aimed at improving all future processes.
Very good overview of a large number of clinical trial topics and the specifics of the Russian market.
Very interesting insight into the latest developments in the Russian market.
